Life Sciences Innovation Forum

Here at Pixels & Pills, we like to push the envelope (or, better, encourage all of you to push it) when it comes to innovation in the healthcare space. That’s why we were so excited to have the opportunity to cover the Life Sciences Innovation Forum, produced by our friends at ExL Pharma in a partnership with Microsoft.

From the website:

The Life Science business environment and model is in a state of accelerating change. More drug approvals occurred in 2011 than any other year in the past decade. This brings some very exciting new opportunities to our industry. The traditional operating model separating Payers, Providers, and Government Health Agencies is under increasing pressures from globalization, healthcare reform, demographic shifts, and emerging healthcare technologies. The Life Sciences Innovation Forum addresses how to excel in this shifting global climate.

There is untapped potential for Pharmaceutical, Medical Device and Biotechnology companies to reap the benefits of the post-reform healthcare market. From discovery to product marketing, from manufacturing and distribution to patients, there are enormous opportunities to better leverage technology to create new business models, further differentiate your organization, and thrive in this dynamic environment.

At the upcoming LS Innovation Forum we are enlisting industry recognized experts and thought leaders to lead engaging sessions that provide you with strategic information to help you achieve goals in areas including:

  • Patient Engagement
  • Leveraging Enterprise Content
  • Global Regulatory Collaboration
  • Innovation Networks
  • Leveraging Health Information Technology

Please take this opportunity to participate in the dialogue and be part of the exciting changes that our industry will experience in the coming months and years.

Register today for this exciting new event.

Date: January 26 & 27, 2012
Location: Marriott Forrestal Village Conference Center, Princeton, NJ
Discount Code: C210PPS



Powered by Facebook Comments

Comments are closed.